Fig nbsp depicts the repetitive

Triflusal, chemically known as 2-acetyloxy-4-trifluoromethyl benzoic acid, is structurally related to acetylsalicylic acid, but, it is not derived from aspirin (acetylsalicylic acid). Triflusal inhibits cycloxygenase-1 in platelets and also favors the production of NO and increases the concentration of cyclic nucleotides [16] and [17]. It is administered orally and gets absorbed in the small intestine. It binds to plasma proteins (99%) and crosses organic barriers readily [18] and [19].